• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Other Resources


The MMTG was established in September 2010 to assist the United States Pharmacopeia (USP) in its efforts to modernize its drug and excipient (inactive ingredient) monographs and associated sections of USP/NF. The MMTG uses a risk-based approach to recommend which USP or NF monographs with antiquated, missing, or nonspecific tests are most in need revision to benefit and protect the public health. These revisions are intended to address deficiencies in current USP/NF tests for identity, quality and purity, and to reduce the risk of adulterated or contaminated drugs being sold in the US.